(Q43250358)

English

In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST). (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Elisabeth Nagy

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Michael J Dowzicky

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

33-38

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments.

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

In vitro activities of tigecycline against the Bacteroides fragilis group

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

In vitro activity of tigecycline against Bacteroides species

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe.

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.3109%2F00365540903244543

21 January 2018

Identifiers

10.3109/00365540903244543

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43250358&oldid=1602396872"